by Aya Gonzalez
Oct 03, 2022A single blind triple arm single dose study to determine the onset, duration and efficacy of ketamine administered IM or IV for low mood states in patients with severe depression with or without suicidal ideation. Received first grant to study ketamine (Intermountain Medical & Research Foundation)
